We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Diabetes mellitus
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
People with diabetes are at risk of permanent sight loss due to damage to the back of their eye, known as the retina. This condition is known as diabetic retinopathy and is the second most common cause of blindness in the UK. In England, people with diabetes are invited to a screening programme where pictures of the retina are taken to look for any signs of disease. If treated early, it can prevent sight loss.
Eye drops are needed to make the pupils big enough to take pictures with the currently available cameras. These drops can sting and blur vision for up to 6 hours afterwards. This means people cannot drive and often cannot work after having the pictures. It is unknown how much these drops impact attendance. Newer cameras, like the iCare Eidon do not require eye drops to take high-quality pictures for most people, but not all.
We would like to investigate if it improves attendance in working age people who usually do not attend.
Our pilot study aims:
1. To explore whether screening without eye drops could increase attendance rates at diabetic eye screening in working age people (aged 18-64), who usually do not attend screening.
This will be measured by the difference in attendance rates in the two arms of the study. The control arm will be offered routine screening with eye drops. The intervention arm will be offered screening with the iCare Eidon without eye drops.
2. To assess the feasibility of a full-scale trial.
We will test if our study design is suitable and can be used for a larger scale trial. We will calculate the number of participants needed for a full-scale trial.
3. To explore the reasons why patients do not attend screening regularly.
This will be assessed through a questionnaire given to patients who attend for screening with the iCare Eidon.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Imaging;
You can take part if:
You may not be able to take part if:
• Any patient with a known ocular co-pathology that would make non-mydriatic imaging impossible. For example, advanced cataracts. • Patients who are unable to adequately position for retinal photography. • Any person who is unable to give informed consent.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST and funded by FIGHT FOR SIGHT .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 65577
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
